IL10 and neoplasm: Finally, emerging evidence suggests that MDSCs may promote immune-escape also by suppressing NK activity, overexpressing programmed death ligands (PD-L1 and PD-L2) and releasing IL-10 and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment (37, 61, 62).